Novella Clinical

Morrisville, United States Founded: 1998 • Age: 28 yrs Acquired By Quintiles
Specialty CRO focussed exclusively solely on the needs of small to mid-sized oncology companies and medical device and diagnostics companies.

About Novella Clinical

Novella Clinical is a Healthcare company based in Morrisville (United States) founded in 1998, and was acquired by Quintiles in August 2013. Specialty CRO focussed exclusively solely on the needs of small to mid-sized oncology companies and medical device and diagnostics companies. Novella Clinical has completed 1 acquisition, including Prologue Research International. Its chief executive, as recorded, is Nick Dyer. Novella Clinical offers products and services including Clinical Development Services, Therapeutic Expertise, and Insights and Resources. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its legal entity is IQVIA Biotech. Its competitors include Aster Insights, CancerVax and Oncotherapeutics; 3 of its 3 listed competitors have raised funding.

Company details

Novella Clinical was founded in 1998 and is based in Morrisville, United States. As an ISO 9001:2008 certified full-service contract research organization, operations are centered on small to mid-sized companies in oncology, medical devices, and diagnostics. Services encompass regulatory planning, project management, clinical monitoring, data management, safety management, medical writing, quality assurance, and post-marketing strategies.

Key Metrics

Products & Services of Novella Clinical

Novella Clinical offers a comprehensive portfolio of products and services, including Clinical Development Services, Therapeutic Expertise, and Insights and Resources.

Clinical Development Services
Research Services

Supports drug development trials in oncology and other therapeutics.

Therapeutic Expertise
Consulting Services

Provides specialized strategies for areas like neurology and dermatology.

Insights and Resources
Data Services

Offers reports and resources for biotech innovation and patient impact.

Investors in Novella Clinical

Novella Clinical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include IQVIA.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Healthcare advancements are driven by IQVIA through connected intelligence.
quintiles.comUnited States
Premium access

Investor details for Novella Clinical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Novella Clinical

1270 people are tracked at Novella Clinical (702 in leadership, 9 in board & advisors, 559 in team).

NameRoleGroup
Nick Dyer
CEOLeadership
Peter Scilipote
Vice President, Business TransformationLeadership
Lynda Curtin
Director Clinical Operations -site ManagementLeadership
Oana Borse
Director, Strategic Sourcing R&dsLeadership
David Peig
Senior Director - Rare Disease BU & GTM StrategyLeadership
Mike Davis
Sr. Director, Strategic Business Development (r&d Solutions)Leadership
Ryan Deterding
Vice President And Global Account DirectorLeadership
Iqbal Thaker
Assoc. Director - IT ProjectsLeadership
Jennifer Millard
Vice PresidentLeadership
Arthur Jenkins
Senior Director, Porfolio Project Management And Development EngineeringLeadership
Manoj Singh
Director Of Software EngineeringLeadership
Ester Pavon
Associate Director, Clinical Project ManagementLeadership
Nuno Dias
Senior Director, IT (head Of Technology)Leadership
Alexey Levashov
Associate Clinical Project Management DirectorLeadership
Chris Nickum
Vice President And General Manager, Commercial Solutions And Insights Hub (csih)Leadership
Fumihiko Ugajin
President - JapanLeadership
Stormie R. Crouch
Senior Director, Business DevelopmentLeadership
Avery Pasch
Account DirectorLeadership
Abbygail Boswell
International Project Associate DirectorLeadership
Susan Grant Schneider
Senior Vice PresidentLeadership

1250 more people are available in the full profile.

Premium access

Complete people profiles for Novella Clinical

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Novella Clinical

Novella Clinical has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Prologue Research International.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Oncology focussed CRO, acquired by Novella Clinical in 2010
procro.comColumbus, United States1998Jun 2010β€’β€’β€’β€’
Premium access

Complete acquisition details for Novella Clinical

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Novella Clinical

3 dated milestones of Novella Clinical across 15 years, from founding to its latest funding, stage changes and deals.

  1. Founded Novella Clinical is founded.
  2. Acquisition Acquires Prologue Research International.
  3. Exit Acquired by Quintiles.

Competitors of Novella Clinical

Novella Clinical has 3 listed competitors in our database, 3 of them funded. They include Aster Insights, CancerVax and Oncotherapeutics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
asterinsights.com2006Tampa, United States$75M115
Contract-based oncology clinical trial services are provided by Aster Insights.
cancervax.com1998Carlsbad, United States$55M
Cancer vaccine research and development is conducted by CancerVax.
oncotherapeutics.com1988West Hollywood, United States$8.3M
Preclinical and clinical oncology drug development services are provided.
Premium access

Detailed competitors of Novella Clinical

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Novella Clinical

Websites that share an audience with Novella Clinical (novellaclinical.com).

Similar websites

Websites whose visitors overlap most with Novella Clinical. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
rhoworld.com
100%
7.9K#2,859,814View details
clinipace.com
92%
View details
quanticate.com
83%
#1,287,633View details
theconferenceforum.org
theconferenceforum.org
79%
#1,939,042–
iconplc.com
78%
476.9K#92,950View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 17 similar websites and full traffic analytics for Novella Clinical

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 17 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Novella Clinical (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Novella Clinical

Novella Clinical was founded in 1998.

Novella Clinical is headquartered in Morrisville, United States.

Nick Dyer is the CEO of Novella Clinical, as recorded in our data.

Novella Clinical was founded in 1998 and is based in Morrisville, United States. As an ISO 9001:2008 certified full-service contract research organization, operations are centered on small to mid-sized companies in oncology, medical devices, and diagnostics. Services encompass regulatory planning, project management, clinical monitoring, data management, safety management, medical writing, quality assurance, and post-marketing strategies.

Novella Clinical's top competitors include CancerVax, Aster Insights and Oncotherapeutics.

Novella Clinical offers Clinical Development Services, Therapeutic Expertise, and Insights and Resources.

Novella Clinical has made 1 acquisition, including Prologue Research International.

Novella Clinical has 1 investor. Key investors include IQVIA.

Novella Clinical operates through Iqvia Biotech.

Yes. Novella Clinical was acquired by Quintiles in August 2013.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available